PMAIP1 and cancer: Consequently, owing to the Noxa-regulating effect of Celastrol, and the Mcl-1-resistant feature of ABT-737, we proposed that the combination of Celastrol with ABT-737 may achieved synergistic anti-cancer activity, and several experiments were performed to prove our hypothesis.